Sodium Phosphate
59 interactions 4 explained in plain EnglishSodium phosphate is used in adults 18 years of age or older to empty the colon (large intestine, bowel) before a colonoscopy (examination of the inside of the colon to check for colon cancer and other abnormalities) so that the doctor will have a clear view of the walls of the colon. Sodium phosphate is in a class of m… Read the full Sodium Phosphate drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Sodium Phosphate Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Sodium Phosphate Sertraline Explained An increased risk of QT interval prolongation Details Sodium Phosphate Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Sodium Phosphate Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Sodium Phosphate Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Sodium Phosphate Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Sodium Phosphate Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Sodium Phosphate Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Sodium Phosphate Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Sodium Phosphate Azithromycin AzaSite An increased risk of QT interval prolongation Details Sodium Phosphate Alfuzosin UroXatral An increased risk of QT interval prolongation Details Sodium Phosphate Anagrelide Agrylin Increased risk of QT interval prolongation Details Sodium Phosphate Bedaquiline Sirturo Increased risk of QT interval prolongation Details Sodium Phosphate Chloroquine Aralen® An increased risk of QT interval prolongation Details Sodium Phosphate Dasatinib Phyrago An increased risk of QT interval prolongation Details Sodium Phosphate Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Sodium Phosphate Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Sodium Phosphate Disopyramide Norpace An increased risk of QT interval prolongation Details Sodium Phosphate Dofetilide Tikosyn An increased risk of QT interval prolongation Details Sodium Phosphate Dolasetron Anzemet An increased risk of QT interval prolongation Details Sodium Phosphate Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Sodium Phosphate Encorafenib Braftovi Increased risk of QT interval prolongation Details Sodium Phosphate Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Sodium Phosphate Erdafitinib Balversa Altered serum phosphate levels Details Sodium Phosphate Flecainide Tambocor® An increased risk of QT interval prolongation Details Sodium Phosphate Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Sodium Phosphate Fostemsavir Rukobia Increased risk of torsade de pointes Details Sodium Phosphate Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Sodium Phosphate Gemifloxacin Factive An increased risk of QT interval prolongation Details Sodium Phosphate Glasdegib Daurismo Increased risk of QT interval prolongation Details Sodium Phosphate Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Sodium Phosphate Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Sodium Phosphate Granisetron Injection Granisol An increased risk of QT interval prolongation Details Sodium Phosphate Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Sodium Phosphate Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Sodium Phosphate Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Sodium Phosphate Ivabradine Corlanor Increased risk of QT prolongation Details Sodium Phosphate Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Sodium Phosphate Lefamulin Xenleta Increased risk of QT interval prolongation Details Sodium Phosphate Lenvatinib Lenvima Increased risk of QT-interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist